Literature DB >> 32623478

Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status.

Ji Ae Lee1,2, Seung-Yeon Yoo1,2, Hyeon Jeong Oh1,2, Seorin Jeong2, Nam-Yun Cho2, Gyeong Hoon Kang1,2, Jung Ho Kim3,4.   

Abstract

It has been suggested that Fusobacterium nucleatum (Fn) may differentially impact tumor immune responses according to microsatellite instability (MSI) status in colorectal cancers (CRCs). We aimed to reveal the detailed relationship between intratumoral Fn and immune microenvironmental features in MSI-high CRCs. A total of 126 MSI-high CRCs were subjected to analyses for intratumoral Fn DNA load using quantitative PCR and for densities of tumor-infiltrating immune cells, including CD3+ T cells, CD4+ T cells, CD8+ T cells, FoxP3+ T cells, CD68+ macrophages, CD163+ macrophages, and CD177+ neutrophils, at invasive margin (IM) and center of tumor (CT) areas using computational image analysis of immunohistochemistry. Based on the Fn load, the 126 MSI-high CRCs were classified into Fn-high, -low, and -negative subgroups. The Fn-high subset of MSI-high CRCs was significantly correlated with larger tumor size and advanced invasion depth (p = 0.017 and p = 0.034, respectively). Compared with the Fn-low/negative subgroup, Fn-high tumors demonstrated significantly lower density of FoxP3+ cells in both IM and CT areas (p = 0.002 and p = 0.003, respectively). Additionally, Fn-high was significantly associated with elevated CD163+ cell to CD68+ cell ratio in only CT areas of MSI-high CRCs (p = 0.028). In conclusion, the Fn-enriched subset of MSI-high CRCs is characterized by increased tumor growth and invasion and distinct immune microenvironmental features, including decreased FoxP3+ T cells throughout the tumor and increased proportion of M2-polarized macrophages in the tumor center. These findings collectively support that Fn may be linked to pro-tumoral immune responses in MSI-high CRCs.

Entities:  

Keywords:  Colorectal carcinoma; Gut microbiome; Gut microbiota; Tumor immunity; Tumor immunology

Mesh:

Year:  2020        PMID: 32623478     DOI: 10.1007/s00262-020-02657-x

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  34 in total

1.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

Authors:  Mara Roxana Rubinstein; Xiaowei Wang; Wendy Liu; Yujun Hao; Guifang Cai; Yiping W Han
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

2.  Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

Authors:  Kosuke Mima; Yasutaka Sukawa; Reiko Nishihara; Zhi Rong Qian; Mai Yamauchi; Kentaro Inamura; Sun A Kim; Atsuhiro Masuda; Jonathan A Nowak; Katsuhiko Nosho; Aleksandar D Kostic; Marios Giannakis; Hideo Watanabe; Susan Bullman; Danny A Milner; Curtis C Harris; Edward Giovannucci; Levi A Garraway; Gordon J Freeman; Glenn Dranoff; Andrew T Chan; Wendy S Garrett; Curtis Huttenhower; Charles S Fuchs; Shuji Ogino
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777

Review 3.  The gut microbiota, bacterial metabolites and colorectal cancer.

Authors:  Petra Louis; Georgina L Hold; Harry J Flint
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

4.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Authors:  Aleksandar D Kostic; Eunyoung Chun; Lauren Robertson; Jonathan N Glickman; Carey Ann Gallini; Monia Michaud; Thomas E Clancy; Daniel C Chung; Paul Lochhead; Georgina L Hold; Emad M El-Omar; Dean Brenner; Charles S Fuchs; Matthew Meyerson; Wendy S Garrett
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

5.  Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism.

Authors:  Ting Chen; Qing Li; Jiao Wu; Yaxin Wu; Wei Peng; Huan Li; Jianmei Wang; Xiaowei Tang; Yan Peng; Xiangsheng Fu
Journal:  Cancer Immunol Immunother       Date:  2018-08-18       Impact factor: 6.968

Review 6.  Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.

Authors:  Caitlin A Brennan; Wendy S Garrett
Journal:  Nat Rev Microbiol       Date:  2019-03       Impact factor: 60.633

Review 7.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

Review 8.  Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.

Authors:  Katsuhiko Nosho; Yasutaka Sukawa; Yasushi Adachi; Miki Ito; Kei Mitsuhashi; Hiroyoshi Kurihara; Shinichi Kanno; Itaru Yamamoto; Keisuke Ishigami; Hisayoshi Igarashi; Reo Maruyama; Kohzoh Imai; Hiroyuki Yamamoto; Yasuhisa Shinomura
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 9.  The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?

Authors:  Karina Wieczorska; Małgorzata Stolarek; Rafał Stec
Journal:  Clin Colorectal Cancer       Date:  2019-07-15       Impact factor: 4.481

10.  Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status.

Authors:  Tsuyoshi Hamada; Xuehong Zhang; Kosuke Mima; Susan Bullman; Yasutaka Sukawa; Jonathan A Nowak; Keisuke Kosumi; Yohei Masugi; Tyler S Twombly; Yin Cao; Mingyang Song; Li Liu; Annacarolina da Silva; Yan Shi; Mancang Gu; Wanwan Li; Hideo Koh; Katsuhiko Nosho; Kentaro Inamura; NaNa Keum; Kana Wu; Jeffrey A Meyerhardt; Aleksandar D Kostic; Curtis Huttenhower; Wendy S Garrett; Matthew Meyerson; Edward L Giovannucci; Andrew T Chan; Charles S Fuchs; Reiko Nishihara; Marios Giannakis; Shuji Ogino
Journal:  Cancer Immunol Res       Date:  2018-09-18       Impact factor: 11.151

View more
  8 in total

Review 1.  Targeting the gut and tumor microbiota in cancer.

Authors:  Elizabeth M Park; Manoj Chelvanambi; Neal Bhutiani; Guido Kroemer; Laurence Zitvogel; Jennifer A Wargo
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

2.  Prediction of Pathogenic Factors in Dysbiotic Gut Microbiomes of Colorectal Cancer Patients Using Reverse Microbiomics.

Authors:  Haihe Wang; Kaibo Zhang; Lin Wu; Qian Qin; Yongqun He
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

Review 3.  Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.

Authors:  Michelle Hanus; Daniela Parada-Venegas; Glauben Landskron; Ana Maria Wielandt; Claudia Hurtado; Karin Alvarez; Marcela A Hermoso; Francisco López-Köstner; Marjorie De la Fuente
Journal:  Front Immunol       Date:  2021-03-26       Impact factor: 7.561

Review 4.  Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer.

Authors:  Eugeniy P Smorodin
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

Review 5.  The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?

Authors:  Jiayao Ma; Lingjuan Huang; Die Hu; Shan Zeng; Ying Han; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2021-10-16

6.  A systematic review of microbial markers for risk prediction of colorectal neoplasia.

Authors:  Lili Yu; Gang Zhao; Lijuan Wang; Xuan Zhou; Jing Sun; Xinxuan Li; Yingshuang Zhu; Yazhou He; Kleovoulos Kofonikolas; Debby Bogaert; Malcolm Dunlop; Yimin Zhu; Evropi Theodoratou; Xue Li
Journal:  Br J Cancer       Date:  2022-03-15       Impact factor: 9.075

Review 7.  Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?

Authors:  Yan Lin; De-Xia Kong; You-Ni Zhang
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

Review 8.  Local Breast Microbiota: A "New" Player on the Block.

Authors:  Marina Vitorino; Diogo Alpuim Costa; Rodrigo Vicente; Telma Caleça; Catarina Santos
Journal:  Cancers (Basel)       Date:  2022-08-05       Impact factor: 6.575

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.